NIH-funded research R01 grant

A brief intervention to reduce anxiety in people with mild cognitive impairment and Alzheimer's disease and their caregivers

Official title: Randomized Clinical Trial of a Brief, Anxiety Intervention for Mild Cognitive Impairment/mild Alzheimer’s Disease and their Care Providers

Funded at Florida State University · NIH-11023050 · Data updated 2026-11-12

This study is testing a short program to help reduce anxiety for people with mild cognitive impairment or Alzheimer's disease and their caregivers, making it easier for them to feel better and enjoy life more.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida State University
NIH-funded
Lab location1 site (Tallahassee, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$667,506
NIH project number5R01AG077569-03
Project IDNIH-11023050 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with mild cognitive impairment or Alzheimer's disease, as well as their caregivers who experience significant anxiety.

Less likely to help

Patients with severe cognitive impairment or advanced Alzheimer's disease may not benefit from this intervention due to the nature of their condition.

What this research studies

This research investigates a brief intervention designed to help reduce anxiety in individuals with mild cognitive impairment (MCI) and Alzheimer's disease, as well as their caregivers. The study aims to address the high prevalence of anxiety symptoms in these populations, which can exacerbate cognitive decline and affect overall well-being. By focusing on anxiety sensitivity, the intervention seeks to provide a more efficient and accessible treatment option that does not rely heavily on cognitive abilities. Participants will engage in a structured program that aims to alleviate anxiety and improve quality of life.

Why it matters

Potential benefit: If successful, this research could lead to effective strategies for managing anxiety in patients with MCI and Alzheimer's disease, enhancing their quality of life.

How similar studies have gone: Previous research has shown promise in using brief interventions to address anxiety in similar populations, suggesting potential for success in this approach.

Where this research is happening

  • Florida State University
    Tallahassee, United States
    Active

Researchers

  • Principal investigator: Schmidt, Norman Brad — Florida State University
  • Study coordinator: Schmidt, Norman Brad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.